Latest Corporate News News
Kimberly-Clark Acquires Kenvue for $40 Billion Amid Controversy
Kimberly-Clark announced a $40 billion acquisition of Kenvue, the Tylenol maker, despite weak sales, lawsuits, and White House criticism over autism claims linked to its painkiller. The deal has puzzled investors but signals bold expansion in consumer health.
Johnson & Johnson Completes Intra-Cellular Therapies Acquisition
Johnson & Johnson finalized its purchase of Intra-Cellular Therapies, Inc., integrating it as a business unit within Johnson & Johnson Innovative Medicine to strengthen neuroscience leadership. This landmark deal bolsters J&J's portfolio in mental health treatments.
Novartis to Buy Avidity Biosciences for $12 Billion
Swiss drugmaker Novartis agreed to acquire U.S. biotech Avidity Biosciences for about $12 billion in cash, aiming to enhance its treatments for rare muscle disorders. The move expands Novartis' rare disease offerings.
Merck Completes Verona Pharma Acquisition
Merck announced the completion of its acquisition of Verona Pharma, making it a wholly-owned subsidiary with Verona's ADS delisted from Nasdaq. The deal focuses on respiratory care advancements.
Sanofi Finalizes Blueprint Medicines Acquisition
Sanofi completed its acquisition of Blueprint Medicines, adding a commercialized medicine for systemic mastocytosis and expertise in KIT-driven diseases to its portfolio. This strengthens Sanofi's rare immunological disease pipeline.
Google Announces $32 Billion Wiz Cybersecurity Buyout
Google revealed the largest tech acquisition of 2025 with a $32 billion buyout of cybersecurity startup Wiz, though the deal remains pending closure. This underscores big tech's push into AI-driven security amid high valuations.
M&A Activity Surges in Q3 with Record 14,720 Deals
Global M&A hit a year-to-date high of 14,720 deals in Q3 2025, with average premiums jumping from 15.5% to 63.25%. Highlights include Norfolk Southern's $88.4 billion merger with Union Pacific and data center deals totaling billions.
FullBeauty Brands Merges with Destination XL Group
FullBeauty Brands agreed to a merger of equals with Destination XL Group, with FullBeauty shareholders owning 55% of the combined public entity under DXLG ticker. A $92 million subscription supports the deal, expected to close in H1 2026.
Cinven, KKR, Providence Sell MasOrange Stake for €4.25 Billion
Cinven, KKR, and Providence completed the sale of their stake in Spanish telecom operator MasOrange for €4.25 billion, marking a successful exit. The transaction, advised by top banks, is set to close in H1 2026 pending approvals.
PNC Receives Regulatory Approvals for FirstBank Acquisition
PNC Financial received regulatory nods to acquire FirstBank, expanding its coast-to-coast presence, with closure expected around January 5, 2026. CEO William Demchak highlighted benefits for customers and communities.
Crescent Energy Stockholders Approve Merger with Vital Energy
Crescent Energy shareholders overwhelmingly approved its merger with Vital Energy, announced on December 12, 2025. The energy sector consolidation aims to enhance operations in key U.S. basins.
Cycle Pharmaceuticals Acquires Applied Therapeutics
Cycle Pharmaceuticals struck a deal to acquire Applied Therapeutics via tender offer at $0.088 per share plus a contingent value right for rare disease treatments. Goodwin Law advised on the clinical-stage biopharma merger.